iShares Biotechnology ETF Rating $137.95 +0.29 (+0.21%) (As of 09:09 AM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.65Holdings in IBB have an aggregate rating of Moderate Buy based on 786 analyst ratings issued in the past year covering 50 companies (83.2% of the portfolio).IBB Aggregate Price Target$137.66High Prediction$137.66Average Prediction$137.66Low Prediction$137.66Holdings in IBB have an aggregate price target of $137.66 and a range of $137.66 to $137.66 covering 50 companies (83.2% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.75%GILDGilead Sciences$92.83+0.0%4.5372 of 5 stars2.67$96.43 3.9%27Insider Trade7.85%VRTXVertex Pharmaceuticals$469.25+0.0%4.2083 of 5 stars2.55$505.73 7.8%31Analyst ForecastPositive News7.05%AMGNAmgen$266.19+0.1%4.5973 of 5 stars2.42$319.68 20.1%26Analyst Downgrade5.27%REGNRegeneron Pharmaceuticals$740.20+0.0%4.7535 of 5 stars2.70$1,052.90 42.2%23Analyst Forecast3.59%IQVIQVIA$197.05+0.2%4.9237 of 5 stars2.90$256.19 30.0%20Short Interest ↓Analyst Revision3.18%ALNYAlnylam Pharmaceuticals$246.58+1.1%4.5509 of 5 stars2.71$298.09 20.9%24Short Interest ↓3.09%ARGXargenx$635.80-0.4%3.1222 of 5 stars2.91$635.11 -0.1%22Short Interest ↓Positive News2.60%MTDMettler-Toledo International$1,244.10-0.2%4.1379 of 5 stars2.00$1,351.25 8.6%9Positive News2.37%BNTXBioNTech$116.09-1.1%2.3177 of 5 stars2.82$140.76 21.3%172.29%BIIBBiogen$150.40-0.2%4.7389 of 5 stars2.48$245.32 63.1%29Analyst Downgrade2.26%ILMNIllumina$141.97-0.8%4.4343 of 5 stars2.70$165.95 16.9%20Short Interest ↑2.25%WATWaters$375.38+0.4%3.8243 of 5 stars2.29$375.85 0.1%141.92%NTRANatera$164.00-2.5%2.1255 of 5 stars3.00$152.67 -6.9%15Gap Down1.74%BGNEBeiGene$179.06+1.5%2.6509 of 5 stars2.75$253.69 41.7%81.60%UTHRUnited Therapeutics$379.694.7106 of 5 stars2.73$370.86 -2.3%15Positive News1.46%MRNAModerna$40.15-1.5%4.4064 of 5 stars2.14$79.50 98.0%22Analyst Downgrade1.40%INCYIncyte$69.18-0.3%4.4745 of 5 stars2.35$76.18 10.1%20Analyst Forecast1.24%INSMInsmed$73.41-0.6%3.1781 of 5 stars3.00$83.67 14.0%16Positive News1.24%NBIXNeurocrine Biosciences$138.48+1.3%4.8855 of 5 stars2.83$166.00 19.9%23Analyst ForecastPositive News1.23%BMRNBioMarin Pharmaceutical$67.00-0.3%4.9834 of 5 stars2.74$94.20 40.6%23Positive News1.20%GMABGenmab A/S$20.77+3.7%4.2563 of 5 stars2.56$45.20 117.6%9Short Interest ↓1.18%SRPTSarepta Therapeutics$125.01-0.6%4.9058 of 5 stars2.91$178.71 43.0%22Insider TradePositive News1.17%TECHBio-Techne$75.10-0.2%4.3205 of 5 stars2.63$82.00 9.2%8Short Interest ↑Positive News1.12%PCVXVaxcyte$90.12+0.3%1.8076 of 5 stars3.00$147.50 63.7%71.00%EXELExelixis$34.98+0.8%4.5611 of 5 stars2.58$31.88 -8.9%19Analyst DowngradeShort Interest ↑1.00%CRLCharles River Laboratories International$190.61+0.7%4.6334 of 5 stars1.93$214.00 12.3%15Positive News0.86%MEDPMedpace$350.97+0.7%4.381 of 5 stars2.45$380.56 8.4%110.84%ITCIIntra-Cellular Therapies$88.00+1.2%4.0755 of 5 stars2.85$97.23 10.5%130.79%RVMDRevolution Medicines$45.05-0.2%4.6668 of 5 stars3.08$63.67 41.3%12Positive News0.77%RGENRepligen$157.94-0.1%3.7685 of 5 stars2.62$185.20 17.3%13Analyst ForecastAnalyst RevisionPositive News0.65%ASNDAscendis Pharma A/S$142.30+1.4%3.2197 of 5 stars2.92$191.77 34.8%13Short Interest ↑0.64%LEGNLegend Biotech$34.52-0.5%1.5344 of 5 stars3.00$81.54 136.2%130.60%HALOHalozyme Therapeutics$49.23+1.3%4.9931 of 5 stars2.60$61.11 24.1%10Positive News0.59%BPMCBlueprint Medicines$95.76-0.7%2.7364 of 5 stars2.71$122.11 27.5%21Insider TradeShort Interest ↑0.59%BRKRBruker$57.49-0.6%4.9938 of 5 stars2.55$74.70 29.9%11Short Interest ↑0.58%CYTKCytokinetics$48.50+1.5%3.9886 of 5 stars2.75$83.93 73.1%160.58%MDGLMadrigal Pharmaceuticals$307.33+0.4%4.3069 of 5 stars2.69$347.33 13.0%13Positive News0.56%ROIVRoivant Sciences$12.05-0.8%2.6787 of 5 stars2.88$17.93 48.8%8Positive News0.48%CRNXCrinetics Pharmaceuticals$54.86-0.9%4.2151 of 5 stars2.91$70.82 29.1%11Analyst ForecastShort Interest ↓Positive News0.47%KRYSKrystal Biotech$167.24-1.1%4.3121 of 5 stars3.00$206.67 23.6%8Analyst Forecast0.47%IONSIonis Pharmaceuticals$37.61-0.2%4.4692 of 5 stars2.68$60.65 61.3%19Short Interest ↓Positive News0.46%ALKSAlkermes$30.75+0.3%4.6842 of 5 stars2.58$35.42 15.2%12Positive News0.46%RNAAvidity Biosciences$32.75+0.0%2.5121 of 5 stars3.00$63.60 94.2%10Gap Down0.45%ADMAADMA Biologics$18.81+1.0%3.8605 of 5 stars3.25$21.25 13.0%4Short Interest ↓0.41%CRSPCRISPR Therapeutics$44.19-1.0%1.8913 of 5 stars2.44$77.93 76.4%18Short Interest ↓0.41%RAREUltragenyx Pharmaceutical$44.66-0.6%4.5688 of 5 stars2.92$87.46 95.8%130.40%NUVLNuvalent$89.00+1.0%2.3475 of 5 stars2.85$112.60 26.5%13Positive News0.38%AXSMAxsome Therapeutics$93.480.0%4.7924 of 5 stars3.00$125.93 34.7%14Short Interest ↓Positive News0.38%BBIOBridgeBio Pharma$27.78-0.1%4.7227 of 5 stars2.86$47.69 71.7%14Analyst Forecast0.37%BHVNBiohaven$39.58+1.2%3.8327 of 5 stars3.07$63.00 59.2%14Analyst Forecast This page (NASDAQ:IBB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts